Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)

NCT03025919 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2017-05-08

No results posted yet for this study

Summary

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Conditions

  • Type II Diabetes Mellitus

Sponsors & Collaborators

  • Zhongda Hospital

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025919 on ClinicalTrials.gov